NEXTURNBIOSCIENCE Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was KRW 0.00014 million compared to KRW 28.33 million a year ago. Net loss was KRW 1,553.17 million compared to net income of KRW 1,782.96 million a year ago.

Basic loss per share from continuing operations was KRW 240 compared to basic earnings per share from continuing operations of KRW 280 a year ago. Basic loss per share was KRW 240 compared to basic earnings per share of KRW 280 a year ago.